334 related articles for article (PubMed ID: 28209220)
1. Very-Low-Density Lipoprotein-Associated Apolipoproteins Predict Cardiovascular Events and Are Lowered by Inhibition of APOC-III.
Pechlaner R; Tsimikas S; Yin X; Willeit P; Baig F; Santer P; Oberhollenzer F; Egger G; Witztum JL; Alexander VJ; Willeit J; Kiechl S; Mayr M
J Am Coll Cardiol; 2017 Feb; 69(7):789-800. PubMed ID: 28209220
[TBL] [Abstract][Full Text] [Related]
2. Independent regulation of plasma apolipoprotein C-II and C-III concentrations in very low density and high density lipoproteins: implications for the regulation of the catabolism of these lipoproteins.
Le NA; Gibson JC; Ginsberg HN
J Lipid Res; 1988 May; 29(5):669-77. PubMed ID: 3411241
[TBL] [Abstract][Full Text] [Related]
3. Plasma apolipoprotein C-III transport in centrally obese men: associations with very low-density lipoprotein apolipoprotein B and high-density lipoprotein apolipoprotein A-I metabolism.
Chan DC; Nguyen MN; Watts GF; Barrett PH
J Clin Endocrinol Metab; 2008 Feb; 93(2):557-64. PubMed ID: 18000086
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E in VLDL and LDL with apolipoprotein C-III is associated with a lower risk of coronary heart disease.
Mendivil CO; Rimm EB; Furtado J; Sacks FM
J Am Heart Assoc; 2013 May; 2(3):e000130. PubMed ID: 23672999
[TBL] [Abstract][Full Text] [Related]
5. Plasma Apolipoproteins Predicting the Occurrence and Severity of Diabetic Retinopathy in Patients With Type 2 Diabetes Mellitus.
Zhang X; Nie Y; Gong Z; Zhu M; Qiu B; Wang Q
Front Endocrinol (Lausanne); 2022; 13():915575. PubMed ID: 35937834
[TBL] [Abstract][Full Text] [Related]
6. Apolipoproteins C-III and A-V as predictors of very-low-density lipoprotein triglyceride and apolipoprotein B-100 kinetics.
Chan DC; Watts GF; Nguyen MN; Barrett PH
Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):590-6. PubMed ID: 16410456
[TBL] [Abstract][Full Text] [Related]
7. Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome.
Julve J; Escolà-Gil JC; Rotllan N; Fiévet C; Vallez E; de la Torre C; Ribas V; Sloan JH; Blanco-Vaca F
Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):232-8. PubMed ID: 19910634
[TBL] [Abstract][Full Text] [Related]
8. Associations of Perfluoroalkyl substances with blood lipids and Apolipoproteins in lipoprotein subspecies: the POUNDS-lost study.
Liu G; Zhang B; Hu Y; Rood J; Liang L; Qi L; Bray GA; DeJonge L; Coull B; Grandjean P; Furtado JD; Sun Q
Environ Health; 2020 Jan; 19(1):5. PubMed ID: 31931806
[TBL] [Abstract][Full Text] [Related]
9. Enrichment of Triglyceride-Rich Lipoproteins with Apolipoprotein C-I Is Positively Associated with Their Delayed Plasma Clearance Independently of Other Transferable Apolipoproteins in Postmenopausal Overweight and Obese Women.
Wassef H; Bissonnette S; Dufour R; Davignon J; Faraj M
J Nutr; 2017 May; 147(5):754-762. PubMed ID: 28356429
[No Abstract] [Full Text] [Related]
10. Reduction in lipoprotein-associated apoC-III levels following volanesorsen therapy: phase 2 randomized trial results.
Yang X; Lee SR; Choi YS; Alexander VJ; Digenio A; Yang Q; Miller YI; Witztum JL; Tsimikas S
J Lipid Res; 2016 Apr; 57(4):706-13. PubMed ID: 26848137
[TBL] [Abstract][Full Text] [Related]
11. Effects of dietary carbohydrate and fat on plasma lipoproteins and apolipoproteins C-II and C-III in healthy men.
Kashyap ML; Barnhart RL; Srivastava LS; Perisutti G; Vink P; Allen C; Hogg E; Brady D; Glueck CJ; Jackson RL
J Lipid Res; 1982 Aug; 23(6):877-86. PubMed ID: 7130856
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein C-III and its defined lipoprotein subspecies in relation to incident diabetes: the Multi-Ethnic Study of Atherosclerosis.
Aroner SA; Furtado JD; Sacks FM; Tsai MY; Mukamal KJ; McClelland RL; Jensen MK
Diabetologia; 2019 Jun; 62(6):981-992. PubMed ID: 30949716
[TBL] [Abstract][Full Text] [Related]
13. Plasma kinetics of apoC-III and apoE in normolipidemic and hypertriglyceridemic subjects.
Batal R; Tremblay M; Barrett PH; Jacques H; Fredenrich A; Mamer O; Davignon J; Cohn JS
J Lipid Res; 2000 May; 41(5):706-18. PubMed ID: 10787431
[TBL] [Abstract][Full Text] [Related]
14. Effects of CETP inhibition with anacetrapib on metabolism of VLDL-TG and plasma apolipoproteins C-II, C-III, and E.
Millar JS; Lassman ME; Thomas T; Ramakrishnan R; Jumes P; Dunbar RL; deGoma EM; Baer AL; Karmally W; Donovan DS; Rafeek H; Wagner JA; Holleran S; Obunike J; Liu Y; Aoujil S; Standiford T; Gutstein DE; Ginsberg HN; Rader DJ; Reyes-Soffer G
J Lipid Res; 2017 Jun; 58(6):1214-1220. PubMed ID: 28314859
[TBL] [Abstract][Full Text] [Related]
15. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins.
Marcoux C; Tremblay M; Fredenrich A; Davignon J; Cohn JS
Metabolism; 2001 Jan; 50(1):112-9. PubMed ID: 11172484
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein C-III displacement of apolipoprotein E from VLDL: effect of particle size.
Breyer ED; Le NA; Li X; Martinson D; Brown WV
J Lipid Res; 1999 Oct; 40(10):1875-82. PubMed ID: 10508207
[TBL] [Abstract][Full Text] [Related]
17. Differences in apolipoprotein and lipid composition between human chylomicron remnants and very low density lipoproteins isolated from fasting and postprandial plasma.
Björkegren J; Karpe F; Milne RW; Hamsten A
J Lipid Res; 1998 Jul; 39(7):1412-20. PubMed ID: 9684744
[TBL] [Abstract][Full Text] [Related]
18. Plasma turnover of HDL apoC-I, apoC-III, and apoE in humans: in vivo evidence for a link between HDL apoC-III and apoA-I metabolism.
Cohn JS; Batal R; Tremblay M; Jacques H; Veilleux L; Rodriguez C; Mamer O; Davignon J
J Lipid Res; 2003 Oct; 44(10):1976-83. PubMed ID: 12867543
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Conventional Lipoprotein Tests and Apolipoproteins in the Prediction of Cardiovascular Disease.
Welsh C; Celis-Morales CA; Brown R; Mackay DF; Lewsey J; Mark PB; Gray SR; Ferguson LD; Anderson JJ; Lyall DM; Cleland JG; Jhund PS; Gill JMR; Pell JP; Sattar N; Welsh P
Circulation; 2019 Aug; 140(7):542-552. PubMed ID: 31216866
[TBL] [Abstract][Full Text] [Related]
20. Fate of apolipoproteins C-1, C-iii, and E during lipolysis of human very low density lipoproteins in vitro.
Tam SP; Dory L; Rubinstein D
J Lipid Res; 1981 May; 22(4):641-51. PubMed ID: 7276737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
